n/a: not applicable. ANA: antinuclear antibodies. SLEDAI: SLE Disease
Activity Index. SLICC: Systemic Lupus International Collaborating
Clinics. SLICC / ACR DI: Systemic Lupus International Collaborating
Clinics / American College of Rheumatology Damage Index. APS:
Antiphospholipid Syndrome.
Results for quantitative variables are shown in Median with
Interquartile Range, and Kruskal Wallis test was used to perform
comparisons between groups. For quantitative variables measured only in
two groups, Mann Whitney U test was used to perform comparisons between
both groups.
The qualitative variables are presented in frequencies, using Chi
squared test to compare between groups.
Only the SLEDAI 2K items that were present in at least one study subject
from either SLE group are shown.
Prednisone dose is shown from the 7 Active SLE patients who had it
prescribed.
|
n/a: not applicable. ANA: antinuclear antibodies. SLEDAI: SLE Disease
Activity Index. SLICC: Systemic Lupus International Collaborating
Clinics. SLICC / ACR DI: Systemic Lupus International Collaborating
Clinics / American College of Rheumatology Damage Index. APS:
Antiphospholipid Syndrome.
Results for quantitative variables are shown in Median with
Interquartile Range, and Kruskal Wallis test was used to perform
comparisons between groups. For quantitative variables measured only in
two groups, Mann Whitney U test was used to perform comparisons between
both groups.
The qualitative variables are presented in frequencies, using Chi
squared test to compare between groups.
Only the SLEDAI 2K items that were present in at least one study subject
from either SLE group are shown.
Prednisone dose is shown from the 7 Active SLE patients who had it
prescribed.
|
n/a: not applicable. ANA: antinuclear antibodies. SLEDAI: SLE Disease
Activity Index. SLICC: Systemic Lupus International Collaborating
Clinics. SLICC / ACR DI: Systemic Lupus International Collaborating
Clinics / American College of Rheumatology Damage Index. APS:
Antiphospholipid Syndrome.
Results for quantitative variables are shown in Median with
Interquartile Range, and Kruskal Wallis test was used to perform
comparisons between groups. For quantitative variables measured only in
two groups, Mann Whitney U test was used to perform comparisons between
both groups.
The qualitative variables are presented in frequencies, using Chi
squared test to compare between groups.
Only the SLEDAI 2K items that were present in at least one study subject
from either SLE group are shown.
Prednisone dose is shown from the 7 Active SLE patients who had it
prescribed.
|
n/a: not applicable. ANA: antinuclear antibodies. SLEDAI: SLE Disease
Activity Index. SLICC: Systemic Lupus International Collaborating
Clinics. SLICC / ACR DI: Systemic Lupus International Collaborating
Clinics / American College of Rheumatology Damage Index. APS:
Antiphospholipid Syndrome.
Results for quantitative variables are shown in Median with
Interquartile Range, and Kruskal Wallis test was used to perform
comparisons between groups. For quantitative variables measured only in
two groups, Mann Whitney U test was used to perform comparisons between
both groups.
The qualitative variables are presented in frequencies, using Chi
squared test to compare between groups.
Only the SLEDAI 2K items that were present in at least one study subject
from either SLE group are shown.
Prednisone dose is shown from the 7 Active SLE patients who had it
prescribed.
|